Literature DB >> 15657640

Botulinum toxin type A in experimental neuropathic pain.

L Bach-Rojecky1, M Relja, Z Lacković.   

Abstract

A peripheral application of botulinum toxin type A (7 U/kg) has significantly reduced thermal and mechanical hypersensitivity in rats with the partial sciatic nerve transection as a classical model of surgical neuropathy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15657640     DOI: 10.1007/s00702-004-0265-1

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  24 in total

1.  Comparison of analgesic effects of single versus repeated injection of botulinum toxin in orofacial formalin test in rats.

Authors:  Ivica Matak; Ivana Stracenski; Zdravko Lacković
Journal:  J Neural Transm (Vienna)       Date:  2012-06-17       Impact factor: 3.575

Review 2.  Evidence-based knee injections for the management of arthritis.

Authors:  Olivia T Cheng; Dmitri Souzdalnitski; Bruce Vrooman; Jianguo Cheng
Journal:  Pain Med       Date:  2012-05-23       Impact factor: 3.750

Review 3.  [Potential antinociceptive mechanisms of botulinum toxin].

Authors:  K R Aoki; J Francis; W H Jost
Journal:  Schmerz       Date:  2006-09       Impact factor: 1.107

4.  Blockade of glutamate release by botulinum neurotoxin type A in humans: a dermal microdialysis study.

Authors:  Larissa Bittencourt da Silva; Ali Karshenas; Flemming Winther Bach; Sten Rasmussen; Lars Arendt-Nielsen; Parisa Gazerani
Journal:  Pain Res Manag       Date:  2014 May-Jun       Impact factor: 3.037

5.  Single intracerebroventricular injection of botulinum toxin type A produces slow onset and long-term memory impairment in rats.

Authors:  Zdravko Lacković; Veseljka Rebić; Peter F Riederer
Journal:  J Neural Transm (Vienna)       Date:  2009-08-20       Impact factor: 3.575

Review 6.  Botulinum toxin type A in motor nervous system: unexplained observations and new challenges.

Authors:  I Matak; Z Lacković; M Relja
Journal:  J Neural Transm (Vienna)       Date:  2016-09-01       Impact factor: 3.575

7.  Dural neurogenic inflammation induced by neuropathic pain is specific to cranial region.

Authors:  B Filipović; I Matak; Z Lacković
Journal:  J Neural Transm (Vienna)       Date:  2013-12-24       Impact factor: 3.575

8.  Antinociceptive action of botulinum toxin type A in carrageenan-induced mirror pain.

Authors:  V Drinovac Vlah; L Bach-Rojecky; Z Lacković
Journal:  J Neural Transm (Vienna)       Date:  2016-08-09       Impact factor: 3.575

Review 9.  Botulinum neurotoxin for pain management: insights from animal models.

Authors:  Flaminia Pavone; Siro Luvisetto
Journal:  Toxins (Basel)       Date:  2010-12-21       Impact factor: 4.546

10.  Critical analysis of the use of onabotulinumtoxinA (botulinum toxin type A) in migraine.

Authors:  Carrie E Robertson; Ivan Garza
Journal:  Neuropsychiatr Dis Treat       Date:  2012-01-13       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.